Synthesis and activity of analogues of the isoleucyl tRNA synthetase inhibitor SB-203207.
Curtis F Crasto, Andrew K Forrest, Tomislav Karoli, Darren R March, Lucy Mensah, Peter J O'Hanlon, Michael R Nairn, Mark D Oldham, Weimin Yue, Martin G Banwell, Christopher J Easton
Research School of Chemistry, Institute of Advanced Studies, Australian National University, Canberra, ACT 0200, Australia.
Bioorganic & medicinal chemistry 2003 Jul 3Twenty two analogues of SB-203207 have been prepared by total synthesis, and evaluated as inhibitors of a range of tRNA synthetases. Changes to the bicyclic core, removing either the terminal amino substituent or the sulfonyl group from the side chain, and altering either the carbon skeleton or stereochemistry of the isoleucine residue, decreases the potency of inhibition of isoleucyl tRNA synthetase. Substituting the isoleucine residue with other amino acids produces inhibitors of the corresponding synthetases. In particular, a methionine derivative is 50-100 times more potent against methionyl tRNA synthetase than against any of the corresponding isoleucyl, leucyl, valyl, alanyl and prolyl synthetases.
Citation
Curtis F Crasto, Andrew K Forrest, Tomislav Karoli, Darren R March, Lucy Mensah, Peter J O'Hanlon, Michael R Nairn, Mark D Oldham, Weimin Yue, Martin G Banwell, Christopher J Easton. Synthesis and activity of analogues of the isoleucyl tRNA synthetase inhibitor SB-203207. Bioorganic & medicinal chemistry. 2003 Jul 3;11(13):2687-94
Mesh Tags
Substances
PMID: 12788342
View Full Text
